Welcome
Services
Drug Discovery Solutions
High-quality leads with Sprint™
Fragment-based lead generation
Kinetic characterization of inhibitors
Ligand deconstruction studies
Competition analysis
Quantitative structure-kinetics modelling and design (QSKR)
Working With Us
Technologies
Sprint™ overview
Sprint™ and SPR biosensors
Sprint™ fragment library
Sprint™ software
Alliances
Contract Research Collaborations
Research Alliances
Media
News
Events
Publications
Images
About Us
Background
Management
Board
Contact
Publications
Latest News
December 6, 2011
-
Beactica and Almac Discovery announce their first fragment-based drug discovery agreement
November 24, 2011
-
Beactica celebrated as Sweden’s fastest growing young biotech at Deloitte’s “Technology Rising Star” awards
October 11, 2011
-
Beactica nominated as “Technology Rising Star” by Deloitte
April 27, 2011
-
Beactica announces fragment-based drug discovery agreement
February 22, 2011
-
Beactica awarded €0.7 million from EU for pioneering influenza research
More News »